CME Group (CME) to Post Quarterly Earnings on Wednesday

CME Group (NASDAQ:CME) is anticipated to release its Q2 2026 results before the market opens on Wednesday, July 22nd. Analysts expect the company to post earnings of $2.92 per share and revenue of $1.6821 billion for the quarter. Individuals are encouraged to explore the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Wednesday, July 22, 2026 at 8:30 AM ET.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping the consensus estimate of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.CME Group’s revenue was up 14.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.80 earnings per share. On average, analysts expect CME Group to post $12 EPS for the current fiscal year and $13 EPS for the next fiscal year.

CME Group Stock Up 0.0%

CME Group stock opened at $245.11 on Tuesday. The stock has a market cap of $88.82 billion, a PE ratio of 20.91, a price-to-earnings-growth ratio of 3.05 and a beta of 0.25. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group has a one year low of $218.31 and a one year high of $329.16. The stock has a fifty day moving average of $257.79 and a 200 day moving average of $281.93.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were given a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend was Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is presently 44.37%.

Insiders Place Their Bets

In other news, insider Hilda Harris Piell sold 5,753 shares of the firm’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the transaction, the insider owned 27,702 shares of the company’s stock, valued at $8,438,860.26. This trade represents a 17.20% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the transaction, the chief executive officer directly owned 55,630 shares in the company, valued at approximately $16,606,111.30. The trade was a 38.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.30% of the company’s stock.

Hedge Funds Weigh In On CME Group

A number of hedge funds have recently modified their holdings of CME. Elkhorn Partners Limited Partnership bought a new stake in shares of CME Group during the 4th quarter valued at $27,000. Strive Asset Management LLC bought a new position in CME Group in the 3rd quarter worth $32,000. Acumen Wealth Advisors LLC bought a new position in CME Group in the 4th quarter worth $33,000. Kemnay Advisory Services Inc. purchased a new stake in CME Group in the 4th quarter worth $39,000. Finally, Uniplan Investment Counsel Inc. increased its stake in CME Group by 281.6% in the 4th quarter. Uniplan Investment Counsel Inc. now owns 145 shares of the financial services provider’s stock worth $40,000 after buying an additional 107 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently commented on the stock. JPMorgan Chase & Co. upped their price target on shares of CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a research report on Thursday, April 16th. Keefe, Bruyette & Woods raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective on the stock in a report on Thursday, June 18th. Erste Group Bank lowered shares of CME Group from a “buy” rating to a “hold” rating in a research report on Friday, June 5th. Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and upped their target price for the company from $316.00 to $323.00 in a report on Thursday, June 11th. Finally, Morgan Stanley decreased their price target on shares of CME Group from $353.00 to $324.00 and set an “overweight” rating on the stock in a research report on Friday, July 10th. Twelve investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $292.12.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.